Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1 to 132 of 132

TitleReference numberPublishedLast updated
3C Patch for treating diabetic foot ulcersMTG66
AMBLor for identifying low-risk non-ulcerated early-stage cutaneous melanomasMIB294
Anifrolumab for treating active autoantibody-positive systemic lupus erythematosus (terminated appraisal)TA793
Antimicrobial prescribing: eravacycline for complicated intra-abdominal infections in adultsES40
Antimicrobial prescribing: oritavancin for acute bacterial skin and skin structure infectionsES39
Atidarsagene autotemcel for treating metachromatic leukodystrophyHST18
Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapyTA788
Belimumab for treating active autoantibody-positive systemic lupus erythematosusTA752
Bladder EpiCheck for detecting bladder cancer recurrenceMIB293
Brain tumours (primary) and brain metastases in over 16sQS203
Cabotegravir with rilpivirine for treating HIV-1TA757
Cemiplimab for treating advanced cutaneous squamous cell carcinomaTA802
Cenobamate for treating focal onset seizures in epilepsyTA753
ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infectionsMTG62
Colorectal cancerNG151
Colorectal cancerQS20
d-Nav insulin management app for type 2 diabetesMIB285
Dapagliflozin for treating chronic kidney diseaseTA775
Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitableTA763
Daratumumab monotherapy for treating relapsed and refractory multiple myelomaTA783
Daratumumab with bortezomib, melphalan and prednisone for untreated multiple myeloma (terminated appraisal)TA771
Depression in adults: treatment and managementNG222
Diabetes in children and young peopleQS125
Diroximel fumarate for treating relapsing–remitting multiple sclerosisTA794
Dostarlimab for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiencyTA779
Dupilumab for treating severe asthma with type 2 inflammationTA751
Durvalumab for maintenance treatment of unresectable non-small-cell lung cancer after platinum-based chemoradiationTA798
EarlyCDT Lung for assessing risk of lung cancer in solid lung nodulesDG46
Elosulfase alfa for treating mucopolysaccharidosis type 4AHST19
Empagliflozin for treating chronic heart failure with reduced ejection fractionTA773
Endo-SPONGE for treating low rectal anastomotic leakMTG63
Endoanchoring systems in endovascular aortic aneurysm repairIPG725
Endobronchial nerve ablation for chronic obstructive pulmonary diseaseIPG714
Endoscopic balloon dilation for subglottic or tracheal stenosisIPG719
Endoscopic full thickness removal of gastrointestinal stromal tumours of the stomachIPG717
Enfortumab vedotin for previously treated locally advanced or metastatic urothelial cancer (terminated appraisal)TA797
Epilepsies in children, young people and adultsNG217
Faricimab for treating diabetic macular oedemaTA799
Faricimab for treating wet age-related macular degenerationTA800
Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosisTA756
Fetal alcohol spectrum disorderQS204
Filgotinib for treating moderately to severely active ulcerative colitisTA792
Freelite assays for diagnosing multiple myeloma and related conditions (terminated assessment)DG47
FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndromeMIB281
Fremanezumab for preventing migraineTA764
Glaucoma: diagnosis and managementNG81
Gout: diagnosis and managementNG219
Granulox for managing chronic non-healing woundsMIB296
Headaches in over 12s: diagnosis and managementCG150
Ibrutinib for treating Waldenstrom's macroglobulinaemiaTA795
icobrain ms for active relapsing–remitting multiple sclerosisMIB291
Integrated health and social care for people experiencing homelessnessNG214
Intramedullary distraction for lower limb lengtheningIPG718
Intramedullary distraction for upper limb lengtheningIPG722
Joint replacement (primary): hip, knee and shoulderQS206
Lenalidomide for relapsed or refractory mantle cell lymphoma (terminated appraisal)TA774
Liposuction for chronic lipoedemaIPG721
Liposuction for chronic lymphoedemaIPG723
Liraglutide for managing obesity in people aged 12 to 17 years (terminated appraisal)TA749
Lumella point-of-care test for assessing pre-eclampsia riskMIB287
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adultsNG215
Mental wellbeing at workNG212
Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disordersTA748
Microwave ablation for primary or metastatic cancer in the lungIPG716
Mogamulizumab for previously treated mycosis fungoides and Sézary syndromeTA754
Multiple sclerosis in adults: managementNG220
myCOPD for managing chronic obstructive pulmonary diseaseMTG68
Neonatal parenteral nutritionQS205
Nerve graft for corneal denervationIPG729
Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancerTA784
Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal)TA785
Nivolumab with ipilimumab for untreated advanced renal cell carcinomaTA780
Odevixibat for treating progressive familial intrahepatic cholestasisHST17
Olaparib for maintenance treatment of BRCA mutation-positive metastatic pancreatic cancer after platinum-based chemotherapy (terminated appraisal)TA750
Olaparib for treating BRCA mutation-positive HER2-negative metastatic breast cancer after chemotherapy (terminated appraisal)TA762
Osimertinib for adjuvant treatment of EGFR mutation-positive non-small-cell lung cancer after complete tumour resectionTA761
Otitis media (acute): antimicrobial prescribingNG91
Palforzia for treating peanut allergy in children and young peopleTA769
Pegcetacoplan for treating paroxysmal nocturnal haemoglobinuriaTA778
Pelvic floor dysfunction: prevention and non-surgical managementNG210
Pembrolizumab for adjuvant treatment of completely resected stage 3 melanomaTA766
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma after stem cell transplant or at least 2 previous therapiesTA772
Pembrolizumab plus chemotherapy for untreated, triple-negative, locally recurrent unresectable or metastatic breast cancerTA801
Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancerTA770
Percutaneous insertion of a cystic duct stent after cholecystostomy for acute calculous cholecystitisIPG720
Peristeen Plus transanal irrigation system for managing bowel dysfunctionMTG36
Personalised external aortic root support (PEARS) using mesh to prevent aortic root expansion and aortic dissection in people with Marfan syndromeIPG724
Pitolisant hydrochloride for treating excessive daytime sleepiness caused by obstructive sleep apnoeaTA776
Ponesimod for treating relapsing–remitting multiple sclerosisTA767
PredictSURE IBD and IBDX to guide treatment of Crohn's diseaseDG45
Preterm labour and birthNG25
Prontosan for treating acute and chronic woundsMTG67
Prostate cancerQS91
Prostate cancer: diagnosis and managementNG131
Reducing sexually transmitted infectionsNG221
Rehabilitation after traumatic injuryNG211
Romosozumab for treating severe osteoporosisTA791
SecurePort IV tissue adhesive for use with percutaneous cathetersMIB288
Sedaconda ACD-S for sedation with volatile anaesthetics in intensive careMTG65
Selpercatinib for previously treated RET fusion-positive advanced non-small-cell lung cancerTA760
Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and overHST20
Sleepio to treat insomnia and insomnia symptomsMTG70
Smart Peak Flow for monitoring asthmaMIB282
Social work with adults experiencing complex needsNG216
Sodium zirconium cyclosilicate for treating hyperkalaemiaTA599
Solriamfetol for treating excessive daytime sleepiness caused by narcolepsyTA758
Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoeaTA777
Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancerTA781
Stereotactic radiosurgery for trigeminal neuralgiaIPG715
Stroke and transient ischaemic attack in over 16s: diagnosis and initial managementNG128
Supercapsular percutaneously assisted total hip arthroplasty for osteoarthritisIPG726
Synthetic cartilage implant insertion for first metatarsophalangeal joint osteoarthritis (hallux rigidus)IPG727
Tagraxofusp for treating blastic plasmacytoid dendritic cell neoplasm (terminated appraisal)TA782
Teduglutide for treating short bowel syndromeTA804
Tepotinib for treating advanced non-small-cell lung cancer with MET gene alterationsTA789
The Insides System for managing intestinal failureMIB286
Thopaz+ portable digital system for managing chest drainsMTG37
Transanal total mesorectal excision for rectal cancerIPG713
TriageHF Plus for remotely monitoring people with cardiac implantable electronic devices at risk of heart failure or worsening heart failureMIB298
Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapiesTA786
Type 2 diabetes in adults: managementNG28
TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices (terminated appraisal)TA790
Upadacitinib for treating active psoriatic arthritis after inadequate response to DMARDsTA768
Urinary incontinence in womenQS77
UroShield for preventing catheter-associated urinary tract infectionsMTG69
Vaccine uptake in the general populationNG218
Vaccine uptake in under 19sQS145
Venetoclax for treating chronic lymphocytic leukaemiaTA796
Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableTA765
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableTA787
Vertebral body tethering for idiopathic scoliosis in children and young peopleIPG728
ViewSite Brain Access System (VBAS) for the surgical management of deep brain lesionsMIB295

Results per page

  1. 10
  2. 25
  3. 50
  4. All